University of California, Los Angeles
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1919-05-23
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucla.edu
Pain Management in ED for Incision and Drainage of Abscess
- First Posted Date
- 2013-06-20
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT01881997
Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
Not Applicable
Completed
- Conditions
- Children at Risk for ASD
- Interventions
- Behavioral: Standard Baby ClassroomBehavioral: Baby JASPER
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2018-10-10
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 110
- Registration Number
- NCT01874327
- Locations
- 🇺🇸
UCLA Semel Institue, Los Angeles, California, United States
Cannabis Effects on Brain Morphology in Aging
Completed
- Conditions
- Study Focuses on Brain Morphology and Cognition in Older Subjects
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 60
- Registration Number
- NCT01874886
- Locations
- 🇺🇸
UCLA Semel/Resnick Neuropsychiatric Institute, Los Angeles, California, United States
Perineal Self-Acupressure
Not Applicable
Completed
- Conditions
- Chronic ConstipationHemorrhoidsConstipation
- Interventions
- Behavioral: Perineal Self-AcupressureBehavioral: Educational Control
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 100
- Registration Number
- NCT01867944
- Locations
- 🇺🇸
UCLA Center for East-West Medicine, Los Angeles, California, United States
Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora
Phase 2
Completed
- Conditions
- BifidobacteriaHealthy Volunteers
- Interventions
- Dietary Supplement: Placebo (Maltodextrin)Dietary Supplement: Xylooligosarcharide 2.8gDietary Supplement: Xylooligosarcharide 1.4g
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 30
- Registration Number
- NCT01861964
- Locations
- 🇺🇸
UCLA Center for Human Nutriiton, Los Angeles, California, United States
🇺🇸UCLA Center for Human Nutrition, David Geffen School of Medicine, Los Angeles, California, United States
Trial of Ibudilast for Methamphetamine Dependence
Phase 2
Completed
- Conditions
- HIV InfectionMethamphetamine Dependence
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 125
- Registration Number
- NCT01860807
- Locations
- 🇺🇸
UCLA Vine Street Clinic, Los Angeles, California, United States
Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene
Phase 1
Completed
- Conditions
- ADA-SCID
- Interventions
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 46
- Registration Number
- NCT01852071
- Locations
- 🇺🇸
Mattel Children's Hospital, UCLA, Los Angeles, California, United States
🇺🇸Mark O. Hatfield Clinical Research Center, NIH, Bethesda, Maryland, United States
Effects of Vitamin D Insufficiency in Man
Not Applicable
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- Dietary Supplement: Vitamin D3Dietary Supplement: Vitamin D2
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 300
- Registration Number
- NCT01848236
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Perceptual Decision Making Under Conditions of Visual Uncertainty
Not Applicable
- Conditions
- Parkinson's DiseaseDystoniaAtaxia
- Interventions
- Procedure: Deep Brain Stimulation (DBS)
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 120
- Registration Number
- NCT01845883
- Locations
- 🇺🇸
Neuroscience Research Building, Los Angeles, California, United States
UCLA-Amity Parolee Health Promotion Study
Not Applicable
Completed
- Conditions
- Hepatitis CDrug AddictionHepatitis BHIV
- Interventions
- Behavioral: Parolee Comprehensive Care + Phone CoachBehavioral: Usual Care GroupBehavioral: Parolee Brief HBV Program + Phone Coach
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 600
- Registration Number
- NCT01844414
- Locations
- 🇺🇸
Amistad de Los Angeles, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath